Jnccn Journal of the National Comprehensive Cancer Network
-
Publication Venue For
-
Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures..
20:1215-1222.e1.
2022
-
NCCN Guidelines® Insights: Survivorship, Version 1.2022..
20:1080-1090.
2022
-
Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance..
20:151-159.
2022
-
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology..
19:1441-1464.
2021
-
Survivorship, Version 1.2021..
19:676-685.
2021
-
NCCN Guidelines Insights: Survivorship, Version 2.2020..
18:1016-1023.
2020
-
Palliative Radiotherapy Versus Esophageal Stent Placement in the Management of Patients With Metastatic Esophageal Cancer..
18:569-574.
2020
-
NCCN Guidelines Insights: Survivorship, Version 2.2019..
17:784-794.
2019
-
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology..
16:1216-1247.
2018
-
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology..
15:1140-1163.
2017
-
Authors' reply to letter to editor: "reply to 'it may be time to abandon urine tests for bladder cancer'".
15:lxxi-lxxii.
2017
-
NCCN Guidelines Insights: Survivorship, Version 1.2016..
14:715-724.
2016
-
NCCN Roundtable: Palliative Care: Providing Comfort From a Patient and Provider Perspective..
14:634-636.
2016
-
Understanding and Utilizing Patient Preferences in Cancer Treatment Decisions..
14:691-693.
2016
-
Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology.
13:1534-1561.
2016
-
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015..
13:1079-1095.
2015
-
Clinical practice guidelines in oncology.
9:1238-1289.
2011
-
Thymic malignancies..
8:1302-1315.
2010
-
Breast cancer: noninvasive and special situations..
8:1182-1207.
2010
-
Pancreatic adenocarcinoma..
8:972-1017.
2010
-
Non-small cell lung cancer..
8:740-801.
2010
-
Operative techniques in early-stage lung cancer..
8:807-813.
2010
-
Bone cancer..
8:688-712.
2010
-
Soft tissue sarcoma..
8:630-674.
2010
-
Genetic/familial high-risk assessment: breast and ovarian..
8:562-594.
2010
-
Gastric cancer..
8:378-409.
2010
-
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors..
8 Suppl 2:S1-41.
2010
-
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas..
8:288-334.
2010
-
NCCN clinical practice guidelines in oncology: prostate cancer early detection..
8:240-262.
2010
-
NCCN clinical practice guidelines in oncology: prostate cancer..
8:162-200.
2010
-
NCCN clinical practice guidelines in oncology. Anal carcinoma..
8:106-120.
2010
-
Radiation therapy advances for treatment of anal cancer..
8:123-129.
2010
-
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis..
7:1060-1096.
2009
-
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia..
7:984-1023.
2009
-
NCCN clinical practice guidelines in oncology: multiple myeloma..
7:908-942.
2009
-
NCCN Clinical Practice Guidelines in Oncology: colon cancer..
7:778-831.
2009
-
NCCN Clinical Practice Guidelines in Oncology: rectal cancer..
7:838-881.
2009
-
NCCN task force report: molecular markers in leukemias and lymphomas..
7 Suppl 4:S1-34.
2009
-
Uterine Neoplasms. Clinical Practice Guidelines in Oncology..
7:498-531.
2009
-
NCCN clinical practice guidelines in oncology: palliative care..
7:436-473.
2009
-
Breast cancer. Clinical practice guidelines in oncology..
7:122-192.
2009
-
Bladder cancer..
7:8-39.
2009
-
Impact of chemotherapy dose intensity on cancer patient outcomes..
7:99-108.
2009
-
Myeloid growth factors..
7:64-83.
2009
-
Acute myeloid leukemia..
6:962-993.
2008
-
Occult primary..
6:1026-1060.
2008
-
Esophageal cancer..
6:818-849.
2008
-
Myelodysplastic syndromes..
6:902-926.
2008
-
Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers..
6:870-878.
2008
-
NCCN Task Force Report: mTOR inhibition in solid tumors..
6 Suppl 5:S1-20.
2008
-
Ovarian cancer. Clinical practice guidelines in oncology..
6:766-794.
2008
-
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology..
6:716-753.
2008
-
Head and neck cancers..
6:646-695.
2008
-
Cancer- and chemotherapy-induced anemia..
6:536-564.
2008
-
Hodgkin disease/lymphoma..
6:594-622.
2008
-
Central nervous system cancers..
6:456-504.
2008
-
Non-Hodgkin's lymphomas..
6:356-421.
2008
-
Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach..
6:436-442.
2008
-
Non-small cell lung cancer..
6:228-269.
2008
-
Small cell lung cancer..
6:294-314.
2008
-
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice..
6:109-118.
2008
-
Cervical cancer..
6:14-36.
2008
-
NCCN Task Force Report. prevention and management of mucositis in cancer care..
6 Suppl 1:S1-21.
2008
-
Cancer-related fatigue. Clinical Practice Guidelines in Oncology..
5:1054-1078.
2007
-
Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology..
5:998-1033.
2007
-
Adult cancer pain..
5:726-751.
2007
-
Prostate Cancer Early Detection.
5:714-714.
2007
-
Prostate cancer early detection. Clinical practice guidelines in oncology..
5:714-736.
2007
-
NCCN task force report: Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines.
5.
2007
-
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines..
5 Suppl 2:S1-29.
2007
-
Chronic myelogenous leukemia..
5:474-496.
2007
-
Bone cancer..
5:420-437.
2007
-
Multiple myeloma. Clinical practice guidelines in oncology..
5:118-147.
2007
-
Myeloid growth factors. Clinical practice guidelines in oncology..
5:188-202.
2007
-
Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy..
5:217-228.
2007
-
Bladder cancer. Clinical guidelines in oncology..
4:984-1014.
2006
-
Kidney cancer. Clinical practice guidelines in oncology..
4:1072-1081.
2006
-
Testicular cancer. Clinical practice guidelines in oncology..
4:1038-1058.
2006
-
Venous thromboembolic disease. Clinical practice guidelines in oncology..
4:838-869.
2006
-
Palliative care. Clinical practice guidelines in oncology..
4:776-818.
2006
-
Computed tomography screening for the early detection of lung cancer..
4:591-594.
2006
-
Non-small cell lung cancer clinical practice guidelines in oncology..
4:548-582.
2006
-
Small cell lung cancer clinical practice guidelines in oncology..
4:602-622.
2006
-
Breast cancer screening and diagnosis..
4:480-508.
2006
-
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology..
4:210-230.
2006
-
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology..
4:258-310.
2006
-
Genetic/familial high-risk assessment: breast and ovarian..
4:156-176.
2006
-
Acute myeloid leukemia clinical practice guidelines in oncology..
4:16-36.
2006
-
Myelodysplastic syndromes clinical practice guidelines in oncology..
4:58-77.
2006
-
Cancer- and treatment-related anemia..
3:772-789.
2005
-
Chronic myelogenous leukemia..
3:732-755.
2005
-
Central nervous system cancers: Clinical Practice Guidelines in Oncology..
3:644-690.
2005
-
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology..
3:598-626.
2005
-
Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence..
3:557-571.
2005
-
Myeloid growth factors clinical practice guidelines in oncology..
3:540-555.
2005
-
Senior adult oncology clinical practice guidelines in oncology..
3:572-590.
2005
-
Head and neck cancers..
3:316-391.
2005
-
Bone cancer clinical practice guidelines..
3:124-140.
2005
-
Occult primary cancer clinical practice guidelines..
3:214-233.
2005
-
Bladder cancer. Clinical practice guidelines in oncology..
3:4-34.
2005
-
Kidney cancer. Clinical practice guidelines..
3:84-93.
2005
-
Testicular cancer. Clinical practice guidelines..
3:52-76.
2005
-
Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials..
1:440-454.
2003
-
Esophageal cancer. Clinical practice guidelines in oncology..
1:14-27.
2003
-
Gastric cancer. Clinical practice guidelines in oncology..
1:28-39.
2003
-
New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor..
1 Suppl 1:S78-S86.
2003
-
Message from the chair of the NCCN Board of Directors.
10:565-566.
2012
-
Cutaneous melanoma: Management of melanoma brain metastases and molecular testing
2021
-
Treatment of locally advanced/metastatic colorectal cancer
2021
-
Trimodal therapy approaches for localized rectal cancer
2020
-
CLO20-049: Retrospective Study of Safety and Toxicity Profile Comparison for Propylene Glycol-Free Melphalan (Evomela®) and Generic Melphalan
2020